Based on the Morgan Stanley stock forecast from 14 analysts, the average analyst target price for Morgan Stanley is USD 113.57 over the next 12 months. Morgan Stanley’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Morgan Stanley is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Morgan Stanley’s stock price was USD 134.99. Morgan Stanley’s stock price has changed by +1.93% over the past week, +14.13% over the past month and +72.03% over the last year.
No recent analyst target price found for Morgan Stanley
No recent average analyst rating found for Morgan Stanley
Frequently Asked Questions About Morgan Stanley (MS) Stock
Based on ratings from 14 analysts Morgan Stanley's stock is Buy . Stock Target Advisor's fundamental analysis is Bearish. The stock has 10 buy, 2 sell and 11 hold ratings.
Unfortunately we do not have enough data on MS's stock to indicate if its a good dividend stock.
Based on targets from 14 analysts, the average taret price for MS is USD 113.57 over the next 12 months. The maximum analyst target price is USD 142 while the minimum anlayst target price is USD 95.
Unfortunately we do not have enough data on MS's stock to indicate if its overvalued.
The last closing price of MS's stock was USD 134.99.
Unfortunately we do not currently have any market capitalization data for MS's stock.
Based on targets from 14 analysts, the average taret price for MS is projected at USD 113.57 over the next 12 months.
This means that MS's stock price may go down by -15.87% over the next 12 months.
We can't find any ETFs which contains Morgan Stanley's stock.
Sorry, we do not have any data on the number of employees for Morgan Stanley.
Sorry we do not have any infomation available on Morgan Stanley's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
What not to like
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Morgan Stanley (MS) Stock
Based on ratings from 14 analysts Morgan Stanley's stock is Buy . Stock Target Advisor's fundamental analysis is Bearish. The stock has 10 buy, 2 sell and 11 hold ratings.
Unfortunately we do not have enough data on MS's stock to indicate if its a good dividend stock.
Based on targets from 14 analysts, the average taret price for MS is USD 113.57 over the next 12 months. The maximum analyst target price is USD 142 while the minimum anlayst target price is USD 95.
Unfortunately we do not have enough data on MS's stock to indicate if its overvalued.
The last closing price of MS's stock was USD 134.99.
Unfortunately we do not currently have any market capitalization data for MS's stock.
Based on targets from 14 analysts, the average taret price for MS is projected at USD 113.57 over the next 12 months.
This means that MS's stock price may go down by -15.87% over the next 12 months.
We can't find any ETFs which contains Morgan Stanley's stock.
Sorry, we do not have any data on the number of employees for Morgan Stanley.
Sorry we do not have any infomation available on Morgan Stanley's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
